News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nvidia shares fell sharply after election- and policy-driven headlines hit AI-related names.
  • The pullback pushed Nvidia below near-term moving averages and into the low end of its 52-week range.
  • Analysts call the dip a tactical buy that creates a defined-risk long trade.
  • The plan targets mean reversion to $210–$220 within about 45 trading days.
  • The strategy uses a strict stop to protect capital and limit losses.
  • The move underscores rising volatility as policy and election news pressure AI sector stocks today.

Latest Articles

U.S. Consumer Inflation Accelerates in August as Gas Prices Rebound

U.S. Consumer Inflation Accelerates in August as Gas Prices Rebound

U.S. consumer prices picked up in August, driven in part by a rebound in gasoline costs, pushing the Consumer Price Index up 0.4% for the month and 3.4% year-on-year. Core CPI, which excludes food and energy, rose 0.3% in August and 2.4% on an annual basis. A stronger Producer Price Index and solid employment figures have increased market expectati…

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

Quantum BioPharma Ltd., trading on NASDAQ as QNTM, announced FDA clearance to initiate phase 2 clinical trials of Lucid-MS, an innovative first-in-class drug candidate aimed at protecting and potentially repairing the myelin sheath in multiple sclerosis patients. The drug represents a novel approach distinct from existing treatments by attempting t…

Antelope Enterprise Holdings Limited Announces Pricing of $6.0 Million Convertible Promissory Note

Antelope Enterprise Holdings Limited Announces Pricing of $6.0 Million Convertible Promissory Note

Antelope Enterprise Holdings Limited announced the pricing of a $6.0 million convertible promissory note to Stratosphere Capital Management, bearing 8% interest with conversion options into common shares at a discounted price. The note has no fixed maturity date, features ownership limitations on conversion, and is intended to provide additional ca…

Draganfly Selected by Government of Canada to Supply Low-Cost Tactical ISR UAS to the Canadian Armed Forces

Draganfly Selected by Government of Canada to Supply Low-Cost Tactical ISR UAS to the Canadian Armed Forces

Draganfly Inc. has been awarded a five-year contract by the Government of Canada to supply Low-Cost Tactical Intelligence, Surveillance and Reconnaissance (ISR) Uncrewed Aircraft Systems (UAS) to the Canadian Armed Forces. The initial contract includes 100 systems with options to supply up to an additional 4,900 units. The contract includes support…

Bond and Watson Realty Corp. Team Up to Transform Personal Security for the Real Estate Industry in the US and Globally

Bond and Watson Realty Corp. Team Up to Transform Personal Security for the Real Estate Industry in the US and Globally

Our Bond, Inc. (NASDAQ: OBAI) has partnered with Watson Realty Corp., a major residential real estate brokerage in Florida and Georgia, to provide Bond’s AI-powered Preventative Personal Security platform to all 800 Watson agents companywide. This rollout coincides with REALTOR® Safety Month and aims to address safety concerns for real estate profe…

Petrobras: Reconfirming My Top Pick — Risk-Managed Entry into PBR

Petrobras: Reconfirming My Top Pick — Risk-Managed Entry into PBR

Petrobras (PBR) remains one of the most compelling income-and-value plays in energy: a $132.9B market-cap integrated oil company trading at a 5.3x P/E with a 5.7% dividend yield, mounting LNG optionality and renewed drilling activity in the Santos pre-salt. Momentum is constructive but stretched, so I’m advocating a risk-managed long with a clear e…

JPMorgan Pulls Back on Chewy, Citing Ongoing Macro Pressure on Organic Sales

JPMorgan Pulls Back on Chewy, Citing Ongoing Macro Pressure on Organic Sales

JPMorgan downgraded Chewy to Neutral from Overweight on Friday, pointing to persistent macroeconomic headwinds that are constraining the online pet retailer's organic growth even as the company shows operational progress. Analyst Doug Anmuth set a December 2027 price target of $24, rooted in roughly seven times his 2028 adjusted EBITDA forecast of …

Exodus Movement, Inc. August 2026 -- Monthly Metrics

Exodus Movement, Inc. August 2026 -- Monthly Metrics

Exodus Movement, Inc. announced strong monthly metrics for August 2026, with a 20% increase in Web3 exchange volumes compared to July and steady monthly active users at 1.4 million. Their payment processing business also showed growth, with gross transaction volumes rising 6% from July and nearly 18% from June, ahead of anticipated operational init…

BGIN BLOCKCHAIN LIMITED to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

BGIN BLOCKCHAIN LIMITED to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

BGIN BLOCKCHAIN LIMITED, a NASDAQ-listed digital asset technology company specializing in cryptocurrency mining, announced its participation at the H.C. Wainwright 28th Annual Global Investment Conference in New York City. The company's management will engage with institutional investors through presentations and one-on-one meetings, aiming to high…

CLIK CEO Buys Shares, Reaffirming Commitment to Long-Term Growth

CLIK CEO Buys Shares, Reaffirming Commitment to Long-Term Growth

Click Holdings Limited's CEO purchased 48,200 shares in the open market, reflecting his commitment to the company's long-term strategy targeting approximately HK$500 million in annual revenue. The company continues to focus on organic growth, strategic initiatives, and potential mergers and acquisitions in its AI-powered HR and senior care services…

Tempest Therapeutics Announces Up to $7.5 Million Private Placement

Tempest Therapeutics Announces Up to $7.5 Million Private Placement

Tempest Therapeutics, a clinical-stage biotech company pioneering in vivo CAR-T therapies for cancer and autoimmune diseases, announced a private placement of common stock and warrants to raise up to $7.5 million. The initial gross proceeds from the offering are expected to be approximately $2.5 million, with potential additional proceeds of $5 mil…